Previous heart failure hospitalization, spironolactone, and outcomes in heart failure with preserved ejection fraction – a secondary analysis of TOPCAT
Authors
Discussion
Loading...
Member takes
Implication
Randomized trial secondary analysis evaluates cardiovascular death and hospitalization in heart failure with preserved ejection fraction, highlighting prior hospitalization timing.
Key Points
- Prior hospitalization for heart failure correlates with adverse outcomes, but the specific influence of timing since discharge remains unclear.
- Secondary analysis of randomized TOPCAT trial data evaluates cardiovascular death and total heart failure hospitalization events under spironolactone.
- Clarifying hospitalization history may optimize treatment decisions with spironolactone for patients with heart failure with preserved ejection fraction.
Cite This Study
Szabó et al. (2024) studied this question.